Press Releases

August
1 Aug 2018 The Medicines Company Reports Second-Quarter 2018 Results
July
26 Jul 2018 The Medicines Company to Announce Second-Quarter 2018 Financial Results on August 1
June
27 Jun 2018 The Medicines Company Announces Recommendation by Independent Data Monitoring Committee to Continue Inclisiran Phase III Trials Following Third Review of Unblinded Data
26 Jun 2018 New Data Presented at the American Diabetes Association 78th Scientific Sessions® Reinforce the Potential of The Medicines Company’s inclisiran in Patients with Diabetes
May
7 May 2018 The Medicines Company Announces Inclisiran Data Showing Significant Reductions in Potentially Harmful Subtypes of Bad Cholesterol (Atherogenic Lipoproteins) Linked to Heart Attack and Stroke
April
30 Apr 2018 The Medicines Company Presents New Data at the National Lipid Association Scientific Sessions
25 Apr 2018 The Medicines Company Reports First-Quarter 2018 Results
19 Apr 2018 The Medicines Company to Announce First-Quarter 2018 Financial Results on April 25
March
27 Mar 2018 The Medicines Company Announces Chief Financial Officer Transition
16 Mar 2018 The Medicines Company to Participate in the Oppenheimer 28th Annual Healthcare Conference
8 Mar 2018 The Medicines Company Reaches Enrollment Target for ORION-10 Ahead of Schedule
8 Mar 2018 The Medicines Company to Participate in the Cowen 38th Annual Health Care Conference
February
27 Feb 2018 The Medicines Company Appoints Dr. Sarah Schlesinger to Its Board of Directors
21 Feb 2018 The Medicines Company Reports Fourth-Quarter and Full-Year 2017 Business and Financial Results
20 Feb 2018 The Medicines Company Reaches Enrollment Target for ORION-9 Ahead of Schedule
14 Feb 2018 The Medicines Company to Host Conference Call and Webcast Discussing Fourth-Quarter and Full-Year 2017 Financial Results
8 Feb 2018 The Medicines Company to Participate in the Leerink Partners 7th Annual Global Healthcare Conference
January
25 Jan 2018 Inclisiran’s First Pivotal Trial Achieves Target Enrollment Ahead of Schedule
8 Jan 2018 The Medicines Company Announces Closing of Divestiture of Infectious Disease Business Unit to Melinta Therapeutics
3 Jan 2018 The Medicines Company to Present at the 36th Annual J. P. Morgan Healthcare Conference